Open original FDA record ↗Recall record
- FDA identifier
- Z-2894-2026
- Company in FDA record
- Aniara Diagnostica LLC
- FDA classification date
- Aug 5, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.
Source facts
- Action
- Email notifications were sent to customers on 6/17/26. Please reply to this email as acknowledgment you have received this initial notification and please include the quantity of each product which is remaining in your possession. A notification letter dated 7/1/26 was sent to customers. Actions to be implemented: " Destroy all stock of 5-PLASMA Bivalirudin Control, 5-PLASMA Bivalirudin Calibrator, & 5-PLASMA AMR Verification Kits - Please permanently deface the box labels and vial labels before disposal. " Complete and return the Awareness Acknowledgement form. " If product has been consumed please add brief statement to the Comment section, complete the End User Information, and return the Awareness Acknowledgement form.
- Initiated
- 2026-07-01
- Root cause
- Process control
- Distribution
- US Nationwide distribution in the states of IL, NC, TN.
- Recall number
- Z-2894-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221367
- FDA classified
- 2026-08-05
- Recall event number
- 99344